News from cellular biomedicine group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 13, 2013, 15:33 ET

Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group, Inc. (OTCQB: CBMG),  a biomedicine firm engaged in the development of new treatments for degenerative and...

Nov 09, 2013, 05:55 ET

Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today convened the annual meeting of its shareholders. Because a quorum was not achieved by...

Nov 07, 2013, 14:45 ET

Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today reminded all its shareholders that the Board of the Company has set November 08, 2013 as...

Nov 05, 2013, 11:36 ET

Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin™ for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Nov 01, 2013, 10:01 ET

Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for...

Oct 30, 2013, 09:01 ET

Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License

Today Cellular Biomedicine Group (OTCQB:CBMG) announced that their A-Stromal™ adipose stromal cell purification kit is ready to launch on the...

Oct 25, 2013, 10:08 ET

Cellular Biomedicine Group calls for General Annual Shareholder Meeting on November 08, 2013

 Cellular Biomedicine Group, Inc. (OTCQB:CBMG) today announced that the Board of the Company has set November 08, 2013 as the date for the...

Oct 14, 2013, 09:44 ET

Cellular Biomedicine Group Appoints Three Independent Directors to the Board

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced that the Board of the Company has appointed three new independent directors to the...

Oct 01, 2013, 07:50 ET

Cellular Biomedicine Group Announces Appointment of New CEO

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) announced today that it has promoted Dr. Wei (William) Cao to serve as its Chief Executive...

Sep 11, 2013, 09:28 ET

Cellular Biomedicine Group Announces Change of Auditor

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and...

Sep 06, 2013, 07:00 ET

Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived...

Aug 22, 2013, 11:48 ET

Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has completed patient enrollment for its Phase I trial to evaluate the safety...

Aug 16, 2013, 11:17 ET

Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and...

Jul 22, 2013, 10:25 ET

Cellular Biomedicine Group Completes Enrollment in Phase I Clinical Trial for Knee Osteoarthritis

Cellular Biomedicine Group (OTCQB:CBMG) today announced that it has completed the enrollment required for its Phase I trial to evaluate the safety...

Jul 11, 2013, 14:39 ET

Cellular Biomedicine Group Appoints Director of Medical Research

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Jun 13, 2013, 07:18 ET

Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

Jun 06, 2013, 07:58 ET

Cellular Biomedicine Group Announces Appointment of Corporate Controller

Cellular Biomedicine Group, Inc. (OTCQB:CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...

May 22, 2013, 08:01 ET

Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved half of the enrollment of the total projected enrollment required for...

May 17, 2013, 08:44 ET

Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved 50% enrollment of the total projected enrollment required for...

Apr 25, 2013, 07:16 ET

Cellular Biomedicine Group Provides Update and 2013 Milestones

 Cellular Biomedicine Group, Inc. (CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and cancers,...